HHV-6

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instance_of gptkb:virus
gptkbp:capsid_shape icosahedral
gptkbp:cause gptkb:roseola
gptkbp:clinical_trial gptkb:pneumonia
gptkb:multiple_sclerosis
febrile seizures
gptkbp:community_health impact on immunocompromised patients
need for awareness in healthcare
potential for outbreaks
gptkbp:condition gptkb:disease
gptkb:HIV/_AIDS
organ transplant complications
gptkbp:diagnosis serology
PCR test
viral culture
gptkbp:discovery_year gptkb:1986
gptkbp:diseases gptkb:chronic_fatigue_syndrome
gptkb:multiple_sclerosis
autoimmune diseases
gptkbp:epidemiology worldwide distribution
gptkbp:family gptkb:Herpesviridae
gptkbp:first_isolation from a patient with roseola
gptkbp:flight_style enveloped virus
gptkbp:genus gptkb:Roseolovirus
gptkbp:has_been_restored can reactivate in immunocompromised individuals
https://www.w3.org/2000/01/rdf-schema#label HHV-6
gptkbp:is_compared_to over 90% in adults
gptkbp:is_vulnerable_to none available
gptkbp:occurs_in high in infants
gptkbp:originated_in T lymphocytes
gptkbp:performance establishes latency in T cells
gptkbp:prevalence common in children
gptkbp:reprints gptkb:Atom
gptkbp:research_focus immune response
vaccine development
viral pathogenesis
gptkbp:seed_dispersal approximately 150 kb
gptkbp:symptoms fever
rash
1 to 2 weeks
gptkbp:transmission saliva
gptkbp:treatment supportive care
corticosteroids
antiviral medications
intravenous immunoglobulin
clinical trials for therapies
investigating antiviral efficacy
studying immune modulation
gptkbp:type_of gptkb:HHV-6_A
gptkb:HHV-6_B
gptkbp:bfsParent gptkb:Herpesviridae
gptkb:herpesviridae_family
gptkbp:bfsLayer 6